Dr Jing Jing Wang is a Senior Research Fellow in Immunology at Flinders University and Head of the Autoimmune Research Group. She is an internationally recognised researcher in systemic autoimmune diseases (SADs), with a focus on lupus, Sjögren’s syndrome, and rheumatoid arthritis.

Dr Wang has established a strong reputation for building high-impact national and international collaborations, underpinning translational advances in autoimmune disease research. Her work centres on developing next-generation approaches to characterise pathogenic autoantibodies at a molecular level—advancing beyond conventional serological diagnostics and opening new pathways for precision therapeutics.

She has pioneered innovative mass spectrometry–based quantitative proteomics to track pathogenic and protective antibody clonotypes over time, alongside integrated transcriptomic–proteomic strategies to identify disease-driving clones within affected tissues. In addition, she has developed a novel reverse-engineering platform to generate recombinant antibodies directly from patient serum, enabling functional interrogation of disease mechanisms.

Dr Wang has an outstanding publication record in leading journals, including Cell, Nature Communications, Annals of the Rheumatic Diseases, Arthritis & Rheumatology, and Journal of Allergy and Clinical Immunology. Her recent landmark discoveries defining the molecular code of pathogenic autoantibodies in adenoviral anti-PF4 disorders and monoclonal gammopathy of thrombotic significance (MGTS) have been published in the New England Journal of Medicine (2024, 2025) and Blood (2022–2024), with all Blood papers accompanied by editorials.

Her research excellence has been recognised through multiple prestigious awards and competitive funding, including an NHMRC Ideas Grant, Gates Foundation funding, an NHMRC Peter Doherty Fellowship, the Philip Alpers Award, the Winnovation SA Emerging Innovator Award, and the Bupa Health Foundation Emerging Researcher Award.